|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02258698 |
|
Date of registration:
|
29/09/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery
|
|
Scientific title:
|
Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery |
|
Date of first enrolment:
|
May 2013 |
|
Target sample size:
|
348 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02258698 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Andrea Kopp Lugli, MD, MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital, Basel, Switzerland |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Aged >18 years
- Admission to the surgical intensive care unit after elective cardiac surgery
(aortocoronary bypass and/or valve repair)
- Being capable of understanding and signing the consent form
Exclusion Criteria:
- Blood glucose values requiring continuous insulin infusion preoperatively
- Ongoing selenium therapy
- Pregnancy
- Interventional valve repair
- Intraoperative hypothermic cardiac arrest
- Off-pump cardiac surgery
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Other Functional Disturbances Following Cardiac Surgery
|
|
Diabetes Mellitus Type 2
|
|
Insulin Resistance
|
|
Intervention(s)
|
|
Procedure: Cardiac surgery
|
|
Primary Outcome(s)
|
|
Number of adverse outcomes in relation to Insulin resistance measured as HOMA (homeostasis model assessment)
[Time Frame: 30 days after surgery]
|
|
Secondary Outcome(s)
|
|
Number of adverse outcomes in relation to Insulin resistance measured as CXCL5
[Time Frame: 30 days after surgery]
|
|
Number of adverse outcomes in relation to Insulin resistance measured as QUICKI
[Time Frame: 30 days after surgery]
|
|
Number of adverse outcomes in relation to Insulin resistance measured as HbA1c
[Time Frame: 30 days after surgery]
|
|
Number of adverse outcomes in relation to Insulin resistance measured as ANGPTL2
[Time Frame: 30 days after surgery]
|
|
Number of adverse outcomes in relation to Insulin resistance measured as irisin
[Time Frame: 30 days after surgery]
|
|
Number of adverse outcomes in relation to Insulin resistance measured as NAMPT
[Time Frame: 30 days after surgery]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|